Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

208 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Inhaled corticosteroids for bronchiectasis.
Kapur N, Petsky HL, Bell S, Kolbe J, Chang AB. Kapur N, et al. Among authors: kolbe j. Cochrane Database Syst Rev. 2018 May 16;5(5):CD000996. doi: 10.1002/14651858.CD000996.pub3. Cochrane Database Syst Rev. 2018. PMID: 29766487 Free PMC article. Review.
Inhaled steroids for bronchiectasis.
Kapur N, Bell S, Kolbe J, Chang AB. Kapur N, et al. Among authors: kolbe j. Cochrane Database Syst Rev. 2009 Jan 21;(1):CD000996. doi: 10.1002/14651858.CD000996.pub2. Cochrane Database Syst Rev. 2009. PMID: 19160186 Updated. Review.
Inhaled steroids for bronchiectasis.
Kolbe J, Wells A, Ram FS. Kolbe J, et al. Cochrane Database Syst Rev. 2000;(2):CD000996. doi: 10.1002/14651858.CD000996. Cochrane Database Syst Rev. 2000. PMID: 10796575 Updated. Review.
Long term effects of denufosol tetrasodium in patients with cystic fibrosis.
Ratjen F, Durham T, Navratil T, Schaberg A, Accurso FJ, Wainwright C, Barnes M, Moss RB; TIGER-2 Study Investigator Group. Ratjen F, et al. J Cyst Fibros. 2012 Dec;11(6):539-49. doi: 10.1016/j.jcf.2012.05.003. Epub 2012 Jun 8. J Cyst Fibros. 2012. PMID: 22682898 Free article. Clinical Trial.
An international, multicentre evaluation and description of Burkholderia pseudomallei infection in cystic fibrosis.
Geake JB, Reid DW, Currie BJ, Bell SC; MelioidCF Investigators; Bright-Thomas R, Dewar J, Holden S, Simmonds N, Gyi K, Kenna D, Waters V, Jackson M, O'Sullivan B, Taccetti G, Kolbe J, O'Carroll M, Campbell D, Jaksic M, Radhakrishna N, Kidd TJ, Flight W. Geake JB, et al. Among authors: kolbe j. BMC Pulm Med. 2015 Oct 9;15:116. doi: 10.1186/s12890-015-0109-9. BMC Pulm Med. 2015. PMID: 26453341 Free PMC article.
A CFTR corrector (lumacaftor) and a CFTR potentiator (ivacaftor) for treatment of patients with cystic fibrosis who have a phe508del CFTR mutation: a phase 2 randomised controlled trial.
Boyle MP, Bell SC, Konstan MW, McColley SA, Rowe SM, Rietschel E, Huang X, Waltz D, Patel NR, Rodman D; VX09-809-102 study group. Boyle MP, et al. Lancet Respir Med. 2014 Jul;2(7):527-38. doi: 10.1016/S2213-2600(14)70132-8. Epub 2014 Jun 24. Lancet Respir Med. 2014. PMID: 24973281 Clinical Trial.
Inhaled, dual release liposomal ciprofloxacin in non-cystic fibrosis bronchiectasis (ORBIT-2): a randomised, double-blind, placebo-controlled trial.
Serisier DJ, Bilton D, De Soyza A, Thompson PJ, Kolbe J, Greville HW, Cipolla D, Bruinenberg P, Gonda I; ORBIT-2 investigators. Serisier DJ, et al. Among authors: kolbe j. Thorax. 2013 Sep;68(9):812-7. doi: 10.1136/thoraxjnl-2013-203207. Epub 2013 May 16. Thorax. 2013. PMID: 23681906 Free PMC article. Clinical Trial.
Phase 2 Trial of the DPP-1 Inhibitor Brensocatib in Bronchiectasis.
Chalmers JD, Haworth CS, Metersky ML, Loebinger MR, Blasi F, Sibila O, O'Donnell AE, Sullivan EJ, Mange KC, Fernandez C, Zou J, Daley CL; WILLOW Investigators. Chalmers JD, et al. N Engl J Med. 2020 Nov 26;383(22):2127-2137. doi: 10.1056/NEJMoa2021713. Epub 2020 Sep 7. N Engl J Med. 2020. PMID: 32897034 Clinical Trial.
208 results